AVTX Avalo Therapeutics, Inc.
Healthcare$16.02-2.02%ClosedMarket Cap: $180.9M
As of 2026-05-26
Insider Statistics (Q2 2026)
Acquisitions
9
Dispositions
34
Buy/Sell Ratio
0.26
Net Shares
-270,987
Shares Acquired
234,946
Shares Disposed
505,933
Total Bought ($)
$0.00
Total Sold ($)
$25.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Tue May 19 | Doyle Mittie | officer: Chief Medical Officer | Sell | 3,000 | $18.76 | 3,622 |
| Tue May 19 | Doyle Mittie | officer: Chief Medical Officer | Sell | 3,000 | $12.65 | 128,625 |
| Mon May 11 | Sullivan Christopher Ryan | officer: Chief Financial Officer | Sell | 18,606 | $24.12 | 423 |
| Mon May 11 | Sullivan Christopher Ryan | officer: Chief Financial Officer | Sell | 18,606 | $9.88 | 168,094 |
| Thu May 07 | VARKI PAUL | officer: Chief Legal Officer | Sell | 37,375 | $18.91 | 41,322 |
| Thu May 07 | VARKI PAUL | officer: Chief Legal Officer | Sell | 22,839 | $21.22 | 13,287 |
| Thu May 07 | VARKI PAUL | officer: Chief Legal Officer | Sell | 9,253 | $22.70 | 4,034 |
| Thu May 07 | VARKI PAUL | officer: Chief Legal Officer | Sell | 5,196 | $19.78 | 36,126 |
| Thu May 07 | VARKI PAUL | officer: Chief Legal Officer | Sell | 400 | $23.71 | 3,634 |
| Thu May 07 | VARKI PAUL | officer: Chief Legal Officer | Sell | 62,500 | $13.43 | 87,500 |
| Thu May 07 | VARKI PAUL | officer: Chief Legal Officer | Sell | 12,563 | $8.04 | 87,437 |
| Thu May 07 | Sullivan Christopher Ryan | officer: Chief Financial Officer | Sell | 47,000 | $8.04 | 116,000 |
| Fri May 01 | Sullivan Christopher Ryan | officer: Chief Financial Officer | Sell | 8,458 | $13.09 | 8,880 |
| Fri May 01 | Sullivan Christopher Ryan | officer: Chief Financial Officer | Sell | 8,457 | $13.23 | 423 |
| Wed Apr 08 | Doyle Mittie | officer: Chief Medical Officer | Sell | 3,970 | $18.01 | 3,622 |